Dear Valued Business Partner,
We are closely monitoring the Coronavirus outbreak, with particular regard to the wellbeing of all our colleagues, our production processes and our supply chain. An internal working group has been established which is regularly assessing the impact, developing potential mitigating actions, and sharing the output with the leadership team. At this stage, assuming that the situation normalises in Q2 and that the outbreak is contained, we do not currently anticipate the outbreak to have any significant impact on our ability to provide patients with the vital products that they need. Our assessments indicate that only a very limited range of our products are impacted.
Critical Care Global Impact
Some of our Critical Care products are manufactured in countries where high levels of Coronavirus have been reported, including China. At present the following product groups may experience some supply issues thru June due to ramp of production in the facilities in China.
- Silicone Foley Catheters & Tracheal Tubes
- Respiratory Care (O2/Aerosol products)
Advanced Wound Care Global Impact
Our Advanced Wound/Continence products, whether produced by Convatec or in partnership with outsourced partners, have very limited manufacturing exposure in countries with high levels of reported cases of Coronavirus.
Ostomy Care Global Impact
Our Ostomy products, whether produced by Convatec or in partnership with outsourced partners, are not manufactured in countries with high levels of reported cases of Coronavirus, this includes China.
The situation is changing daily and therefore, Convatec has a dedicated team tasked with continually reviewing the situation, maintaining close collaboration with our suppliers and logistics partners, and communicating changes as the situation evolves.
If you have any questions, please contact your local Convatec representative or US Convatec Customer Service (phone: 01244 284 882 or email: email@example.com).
Convatec, Global Supply Chain